COMMUNIQUÉS West-GlobeNewswire

Tauriga Sciences Inc. Tenders One-Time Cash Payment of $43,045.00 to Fully Repay and Retire the Final Outstanding Convertible Debenture Held by Adar Bays, LLC
06/03/2018
NEW YORK, NY, March 06, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
Aino Health AB (publ): signs contract with Tampereen Sähkölaitos
06/03/2018
Aino Health signs contract with Tampereen Sähkölaitos, an energy group operating in the city of Tampere in Finland, regarding Aino consulting services. Aino offers consulting services to support the occupational health [...]
Teleradiology Provider Reports 400% Increase in Radiologist Productivity while Simultaneously Increasing the Number of Studies Read by 250% after Implementing Exa PACS/RIS
06/03/2018
WAYNE, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Nine months after the implementation of Exa PACS from Konica Minolta Healthcare Americas, Inc., Radiology Imaging Solutions, a Grand Rapids, Michigan-based teleradiology [...]
Sienna Biopharmaceuticals to Present at Cowen and Company Health Care Conference
06/03/2018
WESTLAKE VILLAGE, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of [...]
Centrus Health and Cerner Collaborate to Deliver Value-Based and Innovative Population Health Care in Kansas City
06/03/2018
KANSAS CITY, Mo., March 06, 2018 (GLOBE NEWSWIRE) -- Centrus Health, a Kansas City-based clinically integrated network, and Cerner, a global leader in health care technology, have come together with a shared vision to [...]
Akcea Therapeutics to Present at Upcoming Investor Conferences
06/03/2018
CAMBRIDGE, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious [...]
Medecision’s population health pioneers to present at HIMSS 2018
06/03/2018
DALLAS and LAS VEGAS, March 06, 2018 (GLOBE NEWSWIRE) -- Medecision , the leader in care and population health management solutions for risk-bearing entities, today announced that the Healthcare Information and [...]
Oxford Immunotec to Present at Two Upcoming Investor Conferences
06/03/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, [...]
Adamis Pharmaceuticals Provides Update on Data Presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Joint Congress With the World Allergy Organization
06/03/2018
SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) (“Adamis”) today provided an update on data from its presentation entitled “Human Factors Study of A Newly Approved [...]
CDx Diagnostics Announces Appointment of New CFO and Executive Vice President of Managed Care
06/03/2018
New Senior Leadership Sets Trajectory for 2018 WATS 3D Commercial Expansion SUFFERN, N.Y., March 06, 2018 (GLOBE NEWSWIRE) -- CDx Diagnostics, an innovator in computer synthesized 3D tissue analysis for the early [...]
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
06/03/2018
LAS VEGAS, March 06, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the February and March 2018 installment obligations under its [...]
Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine
06/03/2018
Presence of antibodies in nasal mucosa suggest vaccine-induced immune protection at source of infection IgA antibodies against RSV observed in both serum and mucosa of vaccinated individuals COPENHAGEN, Denmark, March 6 [...]
Abattis Rebrands as a Downstream Solutions Provider for the Cannabis Market
06/03/2018
VANCOUVER, British Columbia, March 06, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has officially rebranded itself as a one-stop [...]
Clinical Genomics Pathology Inc. receives licensure from Florida Agency for Healthcare Administration
06/03/2018
BRIDGEWATER, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer testing and solutions, is pleased to announce that its CLIA licensed and CAP accredited New Jersey [...]
ChemoCentryx to Present at the Cowen and Company 38th Annual Health Care Conference
06/03/2018
MOUNTAIN VIEW, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the Cowen and Company [...]
Assure Holdings to Present at the 30th Annual ROTH Conference on March 13, 2018
06/03/2018
PARKER, Colo., March 06, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the 30 [...]
Onconova Therapeutics to Present at the 30th Annual Roth Conference in March
06/03/2018
NEWTOWN, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]
Relievant Appoints Christopher Geyen Chief Financial Officer
06/03/2018
SUNNYVALE, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company that has developed the Intracept ® Procedure, a minimally invasive and clinically proven approach for [...]
Corvus Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference 2018
06/03/2018
BURLINGAME, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]

Pages